Exelixis Clinical Site #77

Madrid 28040

1 studies enrolling now · 2 studies all time

What they study most

Castration-resistant Prostate Cancer, Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer, Colorectal Cancer (CRC), Differentiated Thyroid Cancer, Drug-Drug Interaction (DDI), Endometrial Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Hepatocellular Carcinoma

Studies at this site

• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors — Recruiting now
• Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors — Running, not enrolling